Author

Jayaram Vijayakrishnan

Institute of Cancer ResearchORCID 0000-0002-8284-2249Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:GWAS / association mapping· 1 Assay:GWAS summary statistics· 1 Assay:scRNA-seq· 1 Approach:statistical model· 1

Frequent Co-Authors

Philip LawiD· 2 shared Richard S. HoulstoniD· 2 shared Abi HydeiD· 1 shared Amit SudiD· 1 shared Carlo MajiD· 1 shared Charlie MillsiD· 1 shared Claire PallesiD· 1 shared Eugene KatsevichiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenomics

Philip LawORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Enhancer-gene regulatory interactions in colorectal cancer revealed through genome-wide CRISPRi perturbations

Philip Law, Jayaram Vijayakrishnan, James Smith, Timothy Barry, Maria Mandelia, Eugene Katsevich, Richard S. Houlston

The paper uses CRISPRi Perturb-seq to identify 238 enhancer-gene regulatory associations in colorectal cancer and integrates chromatin data to understand their spatial organization.

Wellcome Open Research · Jul 30, 2026Peer-reviewedGenomics

Risk factors for eight common cancers revealed from a phenome-wide Mendelian randomisation analysis of 378,142 cases and 485,715 controls

Molly Went, Amit Sud, Charlie Mills, Abi Hyde, Richard Culliford, Philip Law, Jayaram Vijayakrishnan, Ines Gockel, Carlo Maj, Johannes Schumacher, Claire Palles, Martin Kaiser, Richard S. Houlston

This study uses Mendelian randomisation to identify causal risk factors for eight cancers, finding both well-established and novel molecular factors.

Nature Communications · Mar 25, 2024Peer-reviewedGenetic & Genomic Medicine